GLP-1-related Antihyperglycemic Medication Use is Associated with Shorter Survival in Patients with Amyotrophic Lateral Sclerosis and Diabetes Mellitus (P11-11.032)
We examined the relationship between glucagon-like-peptide-1 (GLP-1) treatments and disease progression among amyotrophic lateral sclerosis (ALS) patients with diabetes mellitus (DM).
Authors
- Ikjae Lee (ORCID: https://orcid.org/0000-0003-0537-9622)
- Jinsy Andrews (ORCID: https://orcid.org/0000-0002-3474-7140)
- Neil A. Shneider (ORCID: https://orcid.org/0000-0002-3223-7366)
- Juen-Haur Hwang (ORCID: https://orcid.org/0000-0003-1873-2472)
- Matthew B. Harms
- Kay Stolwyk
Institutions
- Columbia University (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000208998
- Citations
- 2
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 2.78